L-dopa reduces cortical high beta LFP activity while inducing dyskinesia.
L-dopa elicits the co-emergence of cortical high gamma LFP activity and dyskinesia.
D1 and D2 agonists individually induce cortical high gamma and dyskinesia.
5-HT1A agonist reduces dyskinesia and cortical high gamma but increases high beta.
Phase-locking of cortical spikes is negatively correlated with high gamma LFP.